Fundraising Fox
/Companies
Sign in

LabGenius

London · Founded 2012 · United Kingdom corporation · 70 employees on LinkedIn · 17 known investors

Find your way into LabGenius

LabGenius develops EVA, an automated discovery engine for identifying and co-optimizing complex therapeutic antibodies such as multispecifics across multiple properties. Its internal pipeline focuses on selectivity-enhanced antibodies for treating solid tumours.

AI & Machine LearningBiotechDeep Tech

Founders & leadership

HR
Harrison RickerbyNamed on SEC filing

Board

JFJames Field
James FieldBoard directorFounder at Octopus Ventures

Investors · 17

Air Street Capitallisted by Air Street CapitalSt. Peter Port · $500K – $10M

How we know: Air Street Capital's portfolio page · the VCSheet dataset · Not right? Tell us

Backedlisted by BackedLondon · $500K – $5M

How we know: Backed's portfolio page · Not right? Tell us

Beast Ventureslisted by Beast VenturesHong Kong

How we know: funding news · Not right? Tell us

Champion Hill Ventureslisted by Champion Hill Ventures$500K – $1M

How we know: Champion Hill Ventures's portfolio page · the VCSheet dataset · Not right? Tell us

Gigafundlisted by GigafundAustin · $1M – $5M

How we know: Gigafund's portfolio page · Not right? Tell us

Jude Gomilalisted by Jude GomilaLynnwood

How we know: Jude Gomila's portfolio page · Not right? Tell us

Kindred Capitallisted by Kindred CapitalLondon

How we know: Kindred Capital's portfolio page · labgeniustx.com · Not right? Tell us

M Ventureslisted by M VenturesLos Angeles · $10.8M

How we know: M Ventures's portfolio page · labgeniustx.com · Not right? Tell us

Obvious Ventureslisted by Obvious VenturesSan Francisco · $250K – $6M

How we know: Obvious Ventures's portfolio page · funding news · labgeniustx.com · Not right? Tell us

Octopus Ventureslisted by Octopus VenturesLondon · $130K – $1.3M

How we know: funding news · labgeniustx.com · Not right? Tell us

Recode Ventureslisted by Recode VenturesSan Franciscovia Armen A. Vidian · inferred

How we know: Recode Ventures's portfolio page · Not right? Tell us

AtomicoreportedLondon

How we know: funding news · labgeniustx.com · Not right? Tell us

Berggruen HoldingsreportedLos Angeles · $200M

How we know: funding news · Not right? Tell us

Lux CapitalreportedNew York · $100K – $100M

How we know: funding news · labgeniustx.com · Not right? Tell us

System.Onereported

How we know: funding news · Not right? Tell us

Also in the syndicate · 1

LG Corp

Funding

SEC filings, press & company announcements

$2.8M disclosed across 1 of 3 rounds · 2017–2024

▶$2.8MraisedOct 2017 · 15 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • James FieldExecutive Officer, Director
  • Harrison RickerbyExecutive Officer, Director
Offering amount
$2.8M
Amount sold
$2.8M
First sale
Oct 2017
Incorporated
Corporation, United Kingdom
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does LabGenius do?
LabGenius develops EVA, an automated discovery engine for identifying and co-optimizing complex therapeutic antibodies such as multispecifics across multiple properties. Its internal pipeline focuses on selectivity-enhanced antibodies for treating solid tumours.
Who are LabGenius's investors?
LabGenius's investors include Acequia Capital (AceCap), Air Street Capital, Backed, Beast Ventures, Champion Hill Ventures, Gigafund, Jude Gomila, Kindred Capital and 8 more.
How much funding has LabGenius raised?
LabGenius has disclosed $2.8M raised across 1 of its 3 known rounds.
Where is LabGenius headquartered?
LabGenius is headquartered in London.